Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring

American Journal of Epidemiology

Volumn 180, Issue 1, 2014, Pages 86-93

  Werler, Martha M ^a   Yazdy, Mahsa M ^a   Kasser, James R ^b   Mahan, Susan T ^b   Meyer, Robert E ^c   Anderka, Marlene ^d   Druschel, Charlotte M ^e   Mitchell, Allen A ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c State Center for Health Statistics   (United States)

^d MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

clubfoot; malformation; medications; pregnancy

Indexed keywords

AMOXICILLIN; ANTIVIRUS AGENT; AZITHROMYCIN; CANNABIS; CETIRIZINE; DIPHENHYDRAMINE; FOLIC ACID; GUAIFENESIN; IBUPROFEN; INSULIN; LORATADINE; METRONIDAZOLE; NAPROXEN; ONDANSETRON; OPIATE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PHENYLEPHRINE; PROMETHAZINE; PROTON PUMP INHIBITOR; PSEUDOEPHEDRINE; SALBUTAMOL; SALICYLIC ACID DERIVATIVE; THYROID HORMONE;

ABNORMALITY; CHILD HEALTH; DRUG; EPIDEMIOLOGY; HEALTH RISK; LIMB; MEDICINE; PREGNANCY; QUESTIONNAIRE SURVEY; RISK FACTOR;

ADULT; ARTICLE; BODY MASS; CLUBFOOT; CONTROLLED STUDY; DRUG USE; ENVIRONMENTAL EXPOSURE; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; MOTHER; POPULATION BASED CASE CONTROL STUDY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; RISK FACTOR; UNITED STATES;

MASSACHUSETTS; NEW YORK [UNITED STATES]; NORTH CAROLINA; UNITED STATES;

CLUBFOOT; MALFORMATION; MEDICATIONS; PREGNANCY;

ADULT; CASE-CONTROL STUDIES; CLUBFOOT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MASSACHUSETTS; MATERNAL AGE; NEW YORK; NORTH CAROLINA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; RISK FACTORS; YOUNG ADULT;

EID: 84903954492     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu096     Document Type: Article

References (35)

1. Roye BD, Hyman J, Roye DP Jr. Congenital idiopathic talipes equinovarus. Pediatr Rev. 2004;25(4):124-130.
2. Miedzybrodzka Z. Congenital talipes equinovarus (clubfoot): a disorder of the foot but not the hand. J Anat. 2003;202(1): 37-42.
3. Sundberg K, Bang J, Smidt-Jensen S, et al. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet. 1997;350(9079):697-703.
4. Philip J, Silver RK, Wilson RD, et al. Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol. 2004;103(6):1164-1173.
5. Pastuszak AL, Schüler L, Speck-Martins CE, et al. Use of misoprostol during pregnancy and Möbius' syndrome in infants. N Engl J Med. 1998;338(26):1881-1885.
6. Vargas FR, Schuler-Faccini L, Brunoni D, et al. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet. 2000;95(4):302-306.
7. Katz DA, Albanese EL, Levinsohn EM, et al. Pulsed color-flow Doppler analysis of arterial deficiency in idiopathic clubfoot. J Pediatr Orthop. 2003;23(1):84-87.
8. David RH, Packard DS Jr, Levinsohn EM, et al. Ischemic necrosis following clubfoot surgery: the purple hallux sign. J Pediatr Orthop B. 2004;13(5):315-322.
9. Keith A. Lord Addison as anatomist. Br J Surg. 1952;39(157): 385-387.
10. Atlas S, Menacho LC, Ures S. Some new aspects in the pathology of clubfoot. Clin Orthop Relat Res. 1980(149):224-228.
11. Nadeem RD, Brown JK, Lawson G, et al. Somatosensory evoked potentials as a means of assessing neurological abnormality in congenital talipes equinovarus. Dev Med Child Neurol. 2000;42(8):525-530.
12. Ippolito E, Ponseti IV. Congenital club foot in the human fetus. A histological study. J Bone Joint Surg Am. 1980;62(1): 8-22.
13. Lu W, Bacino CA, Richards BS, et al. Studies of TBX4 and chromosome 17q23.1q23.2: an uncommon cause of nonsyndromic clubfoot. Am J Med Genet A. 2012;158A(7): 1620-1627.
14. Honein MA, Paulozzi LJ, Moore CA. Family history, maternal smoking, and clubfoot: an indication of a gene-environment interaction. Am J Epidemiol. 2000;152(7):658-665.
15. Dickinson KC, Meyer RE, Kotch J. Maternal smoking and the risk for clubfoot in infants. Birth Defects Res A Clin Mol Teratol. 2008;82(2):86-91.
16. Werler MM, Yazdy MM, Mitchell AA, et al. Descriptive epidemiology of idiopathic clubfoot. Am J Med Genet A. 2013; 161A(7):1569-1578.
17. Richards ID. Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med. 1969;23(4): 218-225.
18. Blaasaas KG, Tynes T, Irgens A, et al. Risk of birth defects by parental occupational exposure to 50 Hz electromagnetic fields: a population based study. Occup Environ Med. 2002;59(2): 92-97.
19. Jones K. Smith's Recognizable Patterns of Human Malformation. 5th ed. Philadelphia, PA: W.B. Saunders, Co.; 1997.
20. Halmesmäki E, Raivio K, Ylikorkala O. A possible association between maternal drinking and fetal clubfoot. N Engl J Med. 1985;312(12):790.
21. Vollset SE, Refsum H, Irgens LM, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr. 2000;71(4):962-968.
22. Byron-Scott R, Sharpe P, Hasler C, et al. A South Australian population-based study of congenital talipes equinovarus. Paediatr Perinat Epidemiol. 2005;19(3):227-237.
23. Cardy AH, Barker S, Chesney D, et al. Pedigree analysis and epidemiological features of idiopathic congenital talipes equinovarus in the United Kingdom: a case-control study. BMC Musculoskelet Disord. 2007;8:62.
24. Harlap S, Shiono PH, Ramcharan S. Congenital abnormalities in the offspring of women who used oral and other contraceptives around the time of conception. Int J Fertil. 1985; 30(2):39-47.
25. Kancherla V, Romitti PA, Caspers KM, et al. Epidemiology of congenital idiopathic talipes equinovarus in Iowa, 1997-2005. Am J Med Genet A. 2010;152A(7):1695-1700.
26. Louik C, Lin AE, Werler MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356(26):2675-2683.
27. Heinonen OP, Sloan D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, Inc.; 1977.
28. Källén BA, Olausson PO. Use of oral decongestants during pregnancy and delivery outcome. Am J Obstet Gynecol. 2006; 194(2):480-485.
29. Yazdy MM, Mitchell AA, Louik C, et al. Use of selective-serotonin reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology. In press.
30. Van Allen MI. Fetal vascular disruptions: mechanisms and some resulting birth defects. Pediatr Ann. 1981;10(6):219-233.
31. Werler MM. Teratogen update: pseudoephedrine. Birth Defects Res A Clin Mol Teratol. 2006;76(6):445-452.
32. Hardman JG, Limbird LE, Gilman AG. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001.
33. Hansen M, Kurinczuk JJ, Milne E, et al. Assisted reproductive technology and birth defects: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(4):330-353.
34. Cederholm M, Haglund B, Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG. 2005;112(4):394-402.
35. Knapp KM, Brogly SB, Muenz DG, et al. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J. 2012;31(2):164-170.